Phase I CRO Benchmarking Report 2022: Service Provider Selection Process, Perceptions and Interactions and Performance and Loyalty – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Phase I CRO Benchmarking (14th Ed.)” report has been added to ResearchAndMarkets.com’s offering.

The CRO Benchmarking report has been designed with two goals. The first is to help sponsors make more informed CRO selections. It can be challenging to find the right fit for a particular sponsor organization or trial. And without prior experience with a CRO, it is difficult to judge how the CRO will perform.

Major Topics:

• Service Provider Selection Process
• Service Provider Perceptions and Interactions
• Service Provider Performance and Loyalty
• Company Service Quality Profiles

186 experienced Phase I outsourcers shared their insights regarding 547 recent service provider encounters. The publisher analyzed a variety of factors around CRO selection and share performance data for 32 CROs on 22 attributes across several categories (Budget Factors, Delivery Factors, Staff Characteristics, Accessibility, and Services).

The second goal of the report is to help CROs optimize operational and marketing strategies. Learning your customers’ assessments of your strengths and weaknesses can be invaluable for both the development and marketing of a successful offering. With this report, you’ll understand in which areas your company’s performance shines and in which areas you may need to close the gap relative to competitors. These insights can then be used to design marketing materials that effectively promote your company’s strengths and differentiators.

Key Topics Covered:

Analysis Note: Outsourcing Requirement

Methodology

Demographics

Number of Ratings per Company

Major Sections

Service Provider Selection Process

• Primary Section Takeaways
• Preferred Provider Agreements
• Selection Attributes
• Use of Outside Consultants for CRO
• Identification and Selection
• Service Provider Perceptions and Interactions
• Primary Section Takeaways
• Phase I Leadership, Familiarity, and Reported Use
• Service Provider Preference
• Service Provider Preference among Users
• Cost Perceptions
• Cost Experience among Users
• Summary Table

Service Provider Performance and Loyalty

• Primary Section Takeaways
• Budget Factors
• Delivery Factors
• Staff Characteristics
• Accessibility
• Services
• A Note on Harvey Ball Calculations
• Performance Across Service Providers
• CRO Performance: Budget Factors
• CRO Performance: Delivery Factors
• CRO Performance: Staff Characteristics
• CRO Performance: Accessibility
• CRO Performance: Services
• Customer Loyalty: 2022
• Customer Loyalty: 3-Year Rolling Average

Company Service Quality Profiles

Study Data

• Phase I Leaders, Unprompted
• Other Responses
• Phase I Leaders, Prompted
• Service Provider Familiarity
• Service Provider Familiarity – Additional Providers
• Service Provider Reported Usage
• Service Provider Preference
• Service Provider Differentiation
• Service Provider Cost Perceptions
• Use of Preferred Providers
• Number of Preferred Providers
• Selection Drivers: Selecting among
• Preferred Providers
• Preferred Provider Attributes Gaining Importance
• Selection Drivers: When Not Using
• Preferred Providers
• Selection Drivers: No Preferred Providers
• Service Provider Attributes Gaining Importance:
• No Preferred Providers
• Use of Outside Consultants for CRO Identification
• and Selection
• Service Provider Drill-downs
  • Altasciences (Algorithme, Vince, WCCT)
  • BioPharma Services Inc
  • Biotrial
  • Catalyst Clinical Research
  • Celerion
  • CHDR
  • Covance/Labcorp
  • CTI Clinical Trial & Consulting
  • DCRI-Duke
  • Eurofins (including bioskin)
  • Frontage
  • ICON (including PRA)
  • Innovaderm
  • Questions about this report
  • IQVIA
  • Lambda
  • Medpace
  • NAMSA (including Clinlogix)
  • Novotech
  • Novum
  • Nuvisan
  • Parexel
  • Pharm-Olam International
  • PPD
  • Precision for Medicine
  • QPS
  • Quotient Clinical
  • SGS Life Sciences
  • Siro Clinpharm
  • Spaulding Clinical
  • Syneos Health (including Synteract)
  • TKL Research
• Worldwide Clinical Trials

Demographics

• Company Type
• Office Location
• Job Title
• Decision-making Responsibility
• Outsourcing Involvement by Phase
• Involvement in Clinical Development
• Therapeutic Areas of Responsibility
• Years of Industry Experience

For more information about this report visit https://www.researchandmarkets.com/r/l78ek1

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900